Publications by authors named "Dan Makrinos"
Article Synopsis
- mRNA-1647 is an experimental mRNA vaccine targeting cytomegalovirus (CMV) that stimulates immune responses by encoding specific viral proteins.
- In a phase 1 trial, healthy adults who received three doses developed strong neutralizing antibodies and increased memory B cells, which persisted for months.
- The vaccine effectively triggered robust T-cell responses, indicating its potential for further clinical development to combat CMV, a virus that poses risks, especially to vulnerable populations.
